Rakesh Kumar
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Research top 2%
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 14
- Angiogenesis and VEGF in Cancer 11
- Protein Kinase Regulation and GTPase Signaling 10
-
- Sperm and Testicular Function 20
- Co-authors
- Liana Adam (5 shared papers)Richard J. Santen (8 shared papers)Ratna K. Vadlamudi (14 shared papers)Suresh Kumar Rayala (10 shared papers)Bramanandam Manavathi (4 shared papers)Robert X.-D. Song (3 shared papers)Mahitosh Mandal (5 shared papers)Christopher J. Barnes (4 shared papers)
- Journals
- Journal of Biological Chemistry (12 papers)Cancer Research (9 papers)Clinical Cancer Research (7 papers)Scientific Reports (7 papers)Bioorganic & Medicinal Chemistry Letters (7 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Rakesh Kumar
165 papers receiving 7.9k citations
Rakesh Kumar's Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 2.1k
- Cancer Research 1.1k
- Molecular Biology 4.7k
- Genetics 1.6k
- Cell Biology 842
Countries citing papers authored by Rakesh Kumar
This map shows the geographic impact of Rakesh Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh Kumar more than expected).
Fields of papers citing papers by Rakesh Kumar
This network shows the impact of papers produced by Rakesh Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh Kumar. The network helps show where Rakesh Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Rakesh Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 454 | |
| 2 | Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity Hit paper breakdown → | 2013 | 392 |
| 3 | 2002 | 357 | |
| 4 | 2000 | 327 | |
| 5 | 2004 | 295 | |
| 6 | 1998 | 266 | |
| 7 | 2008 | 252 | |
| 8 | 2009 | 196 | |
| 9 | 2014 | 181 | |
| 10 | 2016 | 180 | |
| 11 | 2005 | 174 | |
| 12 | 2004 | 159 | |
| 13 | 1998 | 156 | |
| 14 | 2000 | 146 | |
| 15 | 2008 | 135 | |
| 16 | 2002 | 128 | |
| 17 | 1998 | 126 | |
| 18 | 2017 | 124 | |
| 19 | 2005 | 122 | |
| 20 | 2014 | 121 |
About Rakesh Kumar
Rakesh Kumar is a scholar working on Molecular Biology, Reproductive Medicine, Oncology, Genetics and Cancer Research, having authored 169 papers that have together received 8.1k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (24 papers), Sperm and Testicular Function (20 papers), PI3K/AKT/mTOR signaling in cancer (14 papers), Reproductive Biology and Fertility (14 papers), Cancer-related Molecular Pathways (12 papers), Effects of Environmental Stressors on Livestock (11 papers), Angiogenesis and VEGF in Cancer (11 papers) and Protein Kinase Regulation and GTPase Signaling (10 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (1.1k citations), Molecular Biology (4.7k citations), Genetics (1.6k citations) and Cell Biology (842 citations). Rakesh Kumar has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Liana Adam, Richard J. Santen, Ratna K. Vadlamudi, Suresh Kumar Rayala, Bramanandam Manavathi, Robert X.-D. Song, Mahitosh Mandal, Christopher J. Barnes, Abhijit Mazumdar and Yongde Bao. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Clinical Cancer Research, Scientific Reports and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.